Quantification of tumor microvessel density, as determined by immunohistochemical staining for ENG, is a significant indicator of poor prognosis in patients with selected solid neoplasias including NSCLC, cervical cancer, prostate cancer, and breast carcinoma [22]. This evidence concerns the gene ENG and neoplasm.